If you made any changes in Pure, your changes will be visible here soon.

Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

  • 3 Similar Profiles
Crohn Disease Medicine & Life Sciences
Inflammatory Bowel Diseases Medicine & Life Sciences
Ulcerative Colitis Medicine & Life Sciences
Celiac Disease Medicine & Life Sciences
Lymphocytosis Medicine & Life Sciences
Biopsy Medicine & Life Sciences
Calciphylaxis Medicine & Life Sciences
Gluten-Free Diet Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2018 2022

Research Output 2010 2019

1 Citation (Scopus)

A longitudinal study of sexual function in women with newly diagnosed inflammatory bowel disease

Shmidt, E., Suárez-Fariñas, M., Mallette, M., Moniz, H., Bright, R., Shah, S. A., Merrick, M., Shapiro, J., Xu, F., Sands, B. & Saha, S., Jun 18 2019, In : Inflammatory Bowel Diseases. 25, 7, p. 1262-1270 9 p.

Research output: Contribution to journalArticle

Inflammatory Bowel Diseases
Longitudinal Studies
Crohn Disease
Demography
Marital Status

Erectile Dysfunction Is Highly Prevalent in Men With Newly Diagnosed Inflammatory Bowel Disease

Shmidt, E., Suárez-Fariñas, M., Mallette, M., Moniz, H., Bright, R., Shah, S. A., Merrick, M., Shapiro, J., Xu, F., Saha, S. & Sands, B. E., Jul 17 2019, In : Inflammatory bowel diseases. 25, 8, p. 1408-1416 9 p.

Research output: Contribution to journalArticle

Erectile Dysfunction
Inflammatory Bowel Diseases
Colitis
Health Surveys
Ulcerative Colitis

Reply to the Letter to the Editor of Dr. Pauwels et al.

Shmidt, E. & Dulai, P. S., Apr 11 2019, In : Inflammatory Bowel Diseases. 25, 5, p. E58

Research output: Contribution to journalLetter

1 Citation (Scopus)

Shorter Disease Duration Is Associated With Higher Rates of Response to Vedolizumab in Patients With Crohn's Disease But Not Ulcerative Colitis

Faleck, D. M., Winters, A., Chablaney, S., Shashi, P., Meserve, J., Weiss, A., Aniwan, S., Koliani-Pace, J. L., Kochhar, G., Boland, B. S., Singh, S., Hirten, R., Shmidt, E., Kesar, V., Lasch, K., Luo, M., Bohm, M., Varma, S., Fischer, M., Hudesman, D. & 14 others, Chang, S., Lukin, D., Sultan, K., Swaminath, A., Gupta, N., Siegel, C. A., Shen, B., Sandborn, W. J., Kane, S., Loftus, E. V., Sands, B. E., Colombel, J. F., Dulai, P. S. & Ungaro, R., Jan 1 2019, In : Clinical Gastroenterology and Hepatology.

Research output: Contribution to journalArticle

Open Access
Ulcerative Colitis
Crohn Disease
Adrenal Cortex Hormones
vedolizumab
Tumor Necrosis Factor-alpha

Correction to: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium (The American Journal of Gastroenterology, (2018), 113, 9, (1345-1354), 10.1038/s41395-018-0162-0)

Narula, N., Peerani, F., Meserve, J., Kochhar, G., Chaudrey, K., Hartke, J., Chilukuri, P., Koliani-Pace, J., Winters, A., Katta, L., Shmidt, E., Hirten, R., Faleck, D., Parikh, M. P., Whitehead, D., Boland, B. S., Singh, S., Sagi, S. V., Fischer, M., Chang, S. & 17 others, Barocas, M., Luo, M., Lasch, K., Bohm, M., Lukin, D., Sultan, K., Swaminath, A., Hudesman, D., Gupta, N., Shen, B., Kane, S., Loftus, E. V., Siegel, C. A., Sands, B. E., Colombel, J. F., Sandborn, W. J. & Dulai, P. S., Jan 1 2018, (Accepted/In press) In : American Journal of Gastroenterology.

Research output: Contribution to journalArticle

Gastroenterology
Licensure
Ulcerative Colitis
vedolizumab